E. Hull-Ryde

发表

Tackling reproducibility in academic preclinical drug discovery

Michelle R. Arkin, Marcie A. Glicksman, P. Jeffrey Conn, 2015, Nature Reviews Drug Discovery.

Quantitation of Amiodarone and Desethylamiodarone from Blood Serum and Myocardium Using Reverse Phase HPLC

J. Lowe, D. Schumacher, J. A. Menius, 1987 .

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.

J. Lehmann, T. Willson, S. Kliewer, 1998, Journal of medicinal chemistry.

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

T. Willson, J. L. Shenk, L. Leesnitzer, 2002, Biochemistry.

High-Affinity Monoclonal Antibodies to PED/PEA-15 Generated Using 5 μg of DNA

K. Kilpatrick, D. Danger, W. Dallas, 2000 .

IRE1α Is a Therapeutic Target for Cystic Fibrosis Airway Inflammation

E. Hull-Ryde, Mary E. B. Martino, Takafumi Kato, 2021, International journal of molecular sciences.

Protective metabolic effects of propranolol during total myocardial ischemia.

J. Lowe, W. Lewis, E. Hull-Ryde, 1986 .

Improved method for high energy nucleotide analysis of canine cardiac muscle using reversed-phase high-performance liquid chromatography.

J. Lowe, E. Hull-Ryde, R. G. Cummings, 1983, Journal of chromatography.

Simple step gradient elution of the major high-energy compounds and their catabolites in cardiac muscle using high-performance liquid chromatography.

J. Lowe, W. Lewis, E. Hull-Ryde, 1986, Journal of chromatography.

XBP1S Regulates MUC5B in a Promoter Variant – Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia

B. Stripp, S. Randell, P. Scherer, 2019 .

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.

J. Lehmann, L. Moore, T. Willson, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Protective metabolic effects of propranolol during total myocardial ischemia.

J. Lowe, W. Lewis, E. Hull-Ryde, 1986, The Journal of thoracic and cardiovascular surgery.

Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro.

C. Sigel, G. B. Wisely, E. Hull-Ryde, 1999, Hybridoma.

Development of a High-Throughput Screening Assay to Identify Inhibitors of the Lipid Kinase PIP5K1C

W. Janzen, M. Zylka, D. Kireev, 2015, Journal of biomolecular screening.

High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides

R. L. Juliano, W. Janzen, R. Juliano, 2015, Nucleic acids research.

AMP Is an Adenosine A1 Receptor Agonist*

Jian Jin, William P. Janzen, Mark J. Zylka, 2012, The Journal of Biological Chemistry.

A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid.

C. Schiffer, W. Janzen, R. Swanstrom, 2013, Biochemistry.

XBP1S Regulates MUC5B in a Promoter Variant-Dependent Pathway in IPF Airway Epithelia.

B. Stripp, S. Randell, P. Scherer, 2019, American journal of respiratory and critical care medicine.

Functional role of the ER stress transducer IRE1α in CF airway epithelial inflammation.

E. Hull-Ryde, C. M. Ribeiro, 2022, Current opinion in pharmacology (Print).

Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.

Joseph E. Rittiner, V. Setola, S. Frye, 2012, Journal of medicinal chemistry.

Evidence that ischemic cell death begins in the subendocardium independent of variations in collateral flow or wall tension.

D. Adams, J. Lowe, D H Adams, 1983, Circulation.

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety.

J. Lehmann, P. Charifson, L. Leesnitzer, 1998, Journal of medicinal chemistry.

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent.

P. Charifson, K. Brown, S. Blanchard, 1998, Journal of medicinal chemistry.

Development of Infrared Imaging to Measure Thermogenesis in Cell Culture: Thermogenic Effects of Uncoupling Protein-2, Troglitazone, and β-Adrenoceptor Agonists

J. Weiel, R. Buckholz, J. Lenhard, 1998, Pharmaceutical Research.

Filtration Improves the Performance of a High-Throughput Screen for Anti-Mycobacterial Compounds

W. Janzen, M. Braunstein, L. Frick, 2014, PloS one.

Identification of small molecule inhibitors that block the Toxoplasma gondii rhoptry kinase ROP18.

Matthieu Schapira, Scott A Wildman, Emily A Hull-Ryde, 2016, ACS infectious diseases.

UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia In Vitro and In Vivo

S. Frye, W. Janzen, H. Earp, 2013, Molecular Cancer Therapeutics.

Identification of Cosalane as an Inhibitor of Human and Murine CC–Chemokine Receptor 7 Signaling via a High-Throughput Screen

M. F. Sassano, W. Janzen, K. Pearce, 2018, SLAS discovery : advancing life sciences R & D.

UNC 569 , a novel small molecule Mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo

S. Frye, W. Janzen, H. Earp, 2013 .